AssayIndex
Contributing laboratory

Medutest

Fast turnaround and the widest compound acceptance, at unit mass resolution rather than high resolution. 940 reports in the index — 14.0 % of the total.

940 reportsgradient 25 minUnit-resolution MSrepeatability 0.26 pp
Section 1

Identification and method basis

Laboratory
Medutest
Short code in this index
Medutest
Location
Ljubljana, Slovenia
Founded
2020
Reports contributed
940
Share of index
14.0%
Purity gradient
25min
Mass resolution
Unit resolution (single quadrupole)
Stated turnaround
2–5 business days
Measured offset vs reference
+0.065 pp
Within-lab repeatability
0.26pp

Medutest is the fastest of the six laboratories and accepts the widest range of submissions, including several compound classes the others decline. Both properties make it a large and useful contributor to index breadth. The trade-off is mass resolution: Medutest's identity confirmation runs on a single-quadrupole instrument at unit resolution, which is adequate for confirming that a 4,113 Da species is present and inadequate for distinguishing species that differ by 1 or 2 Da.

The consequence is specific and the index enforces it. For the compound pairs where a small mass difference is the whole question — bremelanotide vs melanotan II (1 Da), hexarelin vs GHRP-6 (14 Da), reduced vs oxidised cyclic peptides (2 Da), deamidated vs parent (1 Da) — a Medutest identity confirmation is recorded as "consistent with" rather than "confirmed", and the record page states which alternative species were not excluded. This is not a criticism of the laboratory; it is a description of what a unit-resolution instrument can and cannot do.

Measured bias is +0.08 pp on 166 paired comparisons, with the widest limits of agreement of the three high-volume labs at ±0.52 pp. The 25-minute gradient is at the index's minimum acceptable length for the acylated incretins.

Section 2

Methods offered

What a laboratory can measure decides what a record can establish. A submission that orders only purity produces a record that names nothing.

  • RP-HPLC purity (%area, 220 nm)
  • LC-MS identity (single-quadrupole, unit resolution)
  • Karl Fischer water
  • appearance and reconstitution assessment
  • endotoxin by gel-clot LAL
Section 3

What this laboratory has measured

Reports 940
Median purity reported 99.06% n=936
Index median 98.99% n=6722
Batches touched 582
05410816292.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=195.50–95.75 %: n=095.75–96.00 %: n=196.00–96.25 %: n=296.25–96.50 %: n=496.50–96.75 %: n=396.75–97.00 %: n=697.00–97.25 %: n=797.25–97.50 %: n=1897.50–97.75 %: n=3597.75–98.00 %: n=4298.00–98.25 %: n=5898.25–98.50 %: n=6898.50–98.75 %: n=8898.75–99.00 %: n=10699.00–99.25 %: n=11099.25–99.50 %: n=9299.50–99.75 %: n=10499.75–100.00 %: n=191median 99.06 Purity (% area) Reports
Figure 1. Distribution of purity figures reported by Medutest. This is not a distribution of material quality — it is a distribution of what this laboratory was sent, which is a different and unrepresentative sample. Compare its shape against another laboratory's rather than its position: a short gradient compresses the left tail because unresolved species are counted into the main peak.
Most-tested compounds hereReportsMedian purity
Semaglutide14599.05
BPC-1578099.30
Tirzepatide7298.63
Retatrutide7098.35
TB-5003999.70
PT-141 (Bremelanotide)3399.58
Liraglutide3099.07
Ipamorelin2799.72
Sermorelin2498.99
CJC-1295 with DAC2399.08
CJC-1295 (no DAC)2398.69
L-Glutathione (reduced)2399.08
Melanotan II2199.21
Semax2099.09
MK-677 (Ibutamoren mesylate)2099.21
N-Acetyl Semax Amide1799.78
Section 4

Agreement with the other laboratories

Each row is a paired analysis: batches where this laboratory and another one both assayed the same physical lot. A difference on a matched pair is bias plus noise, and it is the only clean way to compare laboratories.

AgainstPaired lotsMean difference (pp)95 % limits of agreementWithin 0.5 pp
Janoshik517+0.065-0.74 to 0.8779%
PeptideMeter362+0.106-0.77 to 0.9871%
VendorInvestigate249+0.559-0.33 to 1.4544%
Nordanalyt224+0.110-0.72 to 0.9475%
Kestrel188-0.370-1.46 to 0.7261%

Positive means Medutest read higher. The full paired analysis, with its assumptions →

Section 5

Provenance of what this laboratory receives

A laboratory that mostly receives supplier-supplied samples produces a record set with a known upward pressure on it, however good its analysis is. This is a property of the submission channel and not of the laboratory.

ProvenanceReportsShareEvidentiary weight
Buyer-sourced859.0%Strongest available evidence in this index.
Supplier-supplied80285.3%Weaker evidence. Read with the caveat below.
Laboratory-retained535.6%Provenance documented, selection uncontrolled.
Section 6

Recent records from this laboratory

The 25 most recent of 940. All records from Medutest →
ReportCompoundSupplierLotQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043368N-Acetyl Semax AmideCPCCPC-2602-D29412026-Q398.796.05102.1Supplier-supplied0PASS
AX-2026-043029RetatrutideKPKP-2607-H52192026-Q395.455.71Supplier-supplied2FAIL
AX-2026-043176Kisspeptin-10GL BiochemGLBI-2608-N80852026-Q398.223.3092.5Buyer-sourced2FAIL
AX-2026-043283L-CarnosineCPCCPC-2603-G16512026-Q398.1010.1291.8Supplier-supplied1FAIL
AX-2026-043365BPC-157CPCCPC-2602-W26462026-Q398.562.80Supplier-supplied1MARGINAL
AX-2026-041385BPC-157WWBWWB-2606-H39062026-Q399.314.31Supplier-supplied1MARGINAL
AX-2026-042797SelankGGPepsGGPE-2602-G20562026-Q398.467.92Buyer-sourced0FAIL
AX-2026-041734CJC-1295 with DACQSCQSC-2602-E94742026-Q399.437.17105.5Supplier-supplied2FAIL
AX-2026-041538RetatrutideQYBQYB-2602-G63082026-Q398.502.85Supplier-supplied2MARGINAL
AX-2026-041390BPC-157WWBWWB-2606-H39062026-Q399.474.8499.3Supplier-supplied1MARGINAL
AX-2026-042481Melanotan IISWBSWB-2603-A57072026-Q398.953.3790.8Supplier-supplied1MARGINAL
AX-2026-041271LiraglutideWWBWWB-2607-X21892026-Q399.935.2495.8Supplier-supplied0PASS
AX-2026-042669CJC-1295 (no DAC)GGPepsGGPE-2606-E84952026-Q398.614.0695.5Supplier-supplied0PASS
AX-2026-042743SelankGGPepsGGPE-2603-J97082026-Q399.599.37Supplier-supplied0PASS
AX-2026-042650Melanotan IIGGPepsGGPE-2603-P87352026-Q399.866.49Supplier-supplied3MARGINAL
AX-2026-042663CJC-1295 (no DAC)GGPepsGGPE-2606-E84952026-Q397.964.1490.0Laboratory-retained2FAIL
AX-2026-042191IpamorelinHomopeptideHOMO-2608-A90452026-Q399.675.00104.6Supplier-supplied1MARGINAL
AX-2026-043420SermorelinWXTWXT-2608-P48672026-Q398.623.0796.4Supplier-supplied0PASS
AX-2026-043105TirzepatideKPKP-2608-D59212026-Q399.085.43Supplier-supplied2MARGINAL
AX-2026-041961TirzepatideTFCTFC-2605-G51342026-Q398.257.11Supplier-supplied2MARGINAL
AX-2026-042068SS-31 (Elamipretide)TFCTFC-2604-Y74722026-Q398.713.6392.9Supplier-supplied2MARGINAL
AX-2026-041926TB-500JEEPJEEP-2605-M48742026-Q399.932.15106.8Supplier-supplied1MARGINAL
AX-2026-041537RetatrutideQYBQYB-2602-G63082026-Q398.143.2390.5Laboratory-retained2MARGINAL
AX-2026-043401SemaglutideWXTWXT-2604-C47282026-Q397.704.7891.5Supplier-supplied1MARGINAL
AX-2026-041981Humanin (HNG)TFCTFC-2605-U55642026-Q399.876.84Supplier-supplied1MARGINAL